Tools and Technology Update

FDA clears low-dose X-ray imager
Biospace med announced that it has received 510k clearance from the Food and Drug Administration (FDA) to market EOS, a new digital X-ray imager in the United States for 2D imaging use. According to the company, the EOS 2D|3D technology allows images to be obtained with a low dose of radiation and is capable of long length digital imaging, permitting full-body, uninterrupted digital imaging with a single scan. The simultaneous biplane image acquisition (front and side images acquired at the same time) eliminates the need for taking a second view and can save time.

The company is also developing an advanced workstation for the U.S. market, designed to generate a 3D skeletal reconstruction from the two simultaneous planar images. This planned product will also feature automatic measurement software designed to calculate a variety of measurements and angle calculations between individual bones and joints, potentially helping to evaluate global balance and posture. EOS 3D is currently commercially available in Europe and Canada only and is not part of the current FDA clearance.

Learn more at http://www.biospacemed.com.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!

Advertisements


Advertisement